SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit
SkinHealth Systems will present findings from two new clinical studies at its Science of Skin Summit in Austin, Texas, running September 17-20, 2026, covering HydraScalp with Keravive and Hydrafacial treatments. A randomized, evaluator-blinded study of a single HydraScalp treatment showed significantly improved scalp hydration, reduced dryness and visible adherent dandruff, and enhanced smoothness while maintaining epidermal barrier integrity.
Key figures
- Drug Name
- HydraScalp with Keravive; Hydrafacial with ReGen GF Booster
- Phase Of Trial
- Phase IV (Hydrafacial open-label study); randomized, evaluator-blinded (HydraScalp study)
- Summit dates
- September 17-20, 2026
- Fitzpatrick skin types
- I-VI
- Hydra Scalp study design
- randomized, evaluator-blinded, single treatment
- Hydrafacial study design
- Phase IV open-label, monthly Deluxe Hydrafacial with Hydrafacial ReGen GF Booster
- Global aesthetic improvement rate
- 100% of subjects
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.